Akso Health (AHG) - 2020 Q4 - Annual Report
Akso Health Akso Health (US:AHG)2020-08-14 20:27

Financial Performance - For the fiscal year ended March 31, 2020, the company reported net revenues of $11,435,060, a decrease of 81.4% compared to $61,330,504 in the previous year[15]. - The total operating costs and expenses for the fiscal year 2020 were $79,962,794, significantly up from $56,232,736 in 2019, marking an increase of 42.2%[15]. - The company experienced a net loss of $71,198,379 for the fiscal year 2020, compared to a net income of $5,532,581 in 2019, indicating a substantial decline in profitability[15]. - Cash and cash equivalents decreased to $10,925,208 as of March 31, 2020, down from $57,372,128 in the previous year, reflecting a decline of 81.0%[17]. - Total assets as of March 31, 2020, were $78,382,476, a decrease from $173,255,842 in 2019, representing a decline of 54.7%[17]. - The company’s basic net income (loss) per share for the fiscal year 2020 was $(1.46), compared to $0.11 in 2019, highlighting a significant downturn in earnings per share[15]. - The company experienced a net cash outflow from operating activities in both 2020 and 2019, indicating potential liquidity challenges[54]. Regulatory Environment - The company ceased to offer new loans for online investors' subscription since November 2019 due to regulatory changes, impacting its operational strategy[20]. - The company has been subject to regulatory uncertainties that may materially affect its growth prospects in the microlending business[29]. - Compliance with regulatory requirements is critical, as any violation could necessitate a material change to the business model, adversely impacting operations[42]. - The evolving regulatory framework for the consumer lending marketplace in China may impact the company's reputation and operational results, especially if associated with non-compliant companies[44]. - The regulatory environment for online microlending companies is evolving, with a suspension of approvals for new online microlending companies since November 2017[94]. - The company must ensure compliance with existing and future laws to avoid sanctions, including the potential revocation of business licenses, which could materially affect operations[87]. - The PRC government may introduce a licensing regime for the marketplace lending service industry, which could hinder the company's ability to operate if licenses are not obtained timely[82]. Business Operations - The company has shifted its focus entirely to credit loans since the third quarter of the fiscal year ended March 31, 2018, with all loans facilitated being credit loans in the fiscal years ended March 31, 2019 and 2020[155]. - The company launched the Xiaobai Maimai platform in May 2020, which offers high-quality products and rewards users for purchases, aiming to enhance user engagement and retention[22]. - The company has experienced a decrease in both the number of borrowers and loan volume facilitated on its marketplace in the fiscal years ended March 31, 2019, and 2020[26]. - The company is in the process of applying for an online microcredit company license in China to refine its business model and identify new opportunities[144]. - The company has connected its credit business assets database with the PBOC Credit Reference Center, enhancing compliance with government regulations but also exposing it to additional cybersecurity risks[33]. Risk Management - The company has stringent risk management protocols in place, but there are concerns about the adequacy of these measures to prevent fraud and assess credit risk effectively[30]. - The company has developed a risk management system that includes database analysis, anti-fraud analysis, manual verification, and post-loan risk management[184]. - The company closely monitors borrower repayments to identify non-payment signs, updating credit scores and grades accordingly[189]. - A risk reserve liability policy protects investors up to the full amount of their investment and accrued interest in case of borrower default, with approximately 1% to 2% of the loan principal set aside as a reserve[194]. Market Trends - The social e-commerce industry in China grew from approximately RMB84.2 billion (US$11.9 billion) in 2018 to an expected RMB564.4 billion (US$79.7 billion) in 2021[22]. - The total addressable market for loans is estimated to grow from RMB410.3 billion (US$57.9 billion) in 2018 to RMB528.4 billion (US$74.6 billion) in 2023, with a CAGR of 5.2%[37]. - Broader macroeconomic factors, such as interest rates and unemployment, may adversely affect borrower interest and investor lending, potentially leading to a decline in loan volume and revenues[54]. Corporate Governance - The company is classified as a "controlled company" under NASDAQ rules, allowing it to phase in compliance with certain corporate governance requirements, which may adversely affect public shareholders[126]. - The company is an emerging growth company and has opted out of certain reduced reporting requirements, including auditor attestation requirements under Section 404[131]. - The company is a foreign private issuer, exempt from certain provisions applicable to U.S. domestic public companies, including quarterly reporting on Form 10-Q[131]. - The company’s ability to expand and engage in corporate transactions may be limited by the substantial influence of existing shareholders[126]. Financial Compliance - The company has not made adequate contributions to employee benefit plans as required by PRC regulations, which may result in penalties and adversely affect its financial condition[109]. - The PRC tax authorities may audit related party transactions, potentially leading to increased tax liabilities if deemed inconsistent with arm's length principles[76]. - The company is subject to various PRC regulations regarding the conversion of foreign currency registered capital into RMB, which may limit its ability to fund operations effectively[104]. Investor Relations - The board of directors approved an annual dividend policy set at approximately 15-25% of anticipated net income after tax, with a total dividend of $0.40 per ordinary share for the fiscal year ended March 31, 2019[123]. - The trading price of the company's ADSs has fluctuated between US$0.42 and US$3.88 in 2019, indicating potential volatility influenced by market and industry factors[120]. - Short selling practices may negatively impact the market price of the company's ADSs, as short sellers may publish negative opinions to drive down prices[121].

Akso Health (AHG) - 2020 Q4 - Annual Report - Reportify